Literature DB >> 17041261

Monobodies: antibody mimics based on the scaffold of the fibronectin type III domain.

Akiko Koide1, Shohei Koide.   

Abstract

We developed the use of the 10th fibronectin type III domain of human fibronectin (FNfn10) as a scaffold to display multiple surface loops for target binding. We termed FNfn10 variants with novel binding function "monobodies." FNfn10 is a small (94 residues) protein with a beta-sandwich structure similar to the immunoglobulin fold. It is highly stable without disulfide bonds or metal ions, and it can be expressed in the correctly folded form at a high level in bacteria. These desirable physical properties render the FNfn10 scaffold compatible with virtually any display technologies. This chapter describes methods for library construction and screening and for the production of monobodies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17041261     DOI: 10.1385/1-59745-187-8:95

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  40 in total

1.  Epidermal growth factor receptor downregulation by small heterodimeric binding proteins.

Authors:  Benjamin J Hackel; Jason R Neil; Forest M White; K Dane Wittrup
Journal:  Protein Eng Des Sel       Date:  2011-12-09       Impact factor: 1.650

2.  Isoform-specific monobody inhibitors of small ubiquitin-related modifiers engineered using structure-guided library design.

Authors:  Ryan N Gilbreth; Khue Truong; Ikenna Madu; Akiko Koide; John B Wojcik; Nan-Sheng Li; Joseph A Piccirilli; Yuan Chen; Shohei Koide
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

3.  A fibronectin scaffold approach to bispecific inhibitors of epidermal growth factor receptor and insulin-like growth factor-I receptor.

Authors:  Stuart L Emanuel; Linda J Engle; Ginger Chao; Rong-Rong Zhu; Carolyn Cao; Zheng Lin; Aaron P Yamniuk; Jennifer Hosbach; Jennifer Brown; Elizabeth Fitzpatrick; Jochem Gokemeijer; Paul Morin; Brent A Morse; Irvith M Carvajal; David Fabrizio; Martin C Wright; Ruchira Das Gupta; Michael Gosselin; Daniel Cataldo; Rolf P Ryseck; Michael L Doyle; Tai W Wong; Raymond T Camphausen; Sharon T Cload; H Nicholas Marsh; Marco M Gottardis; Eric S Furfine
Journal:  MAbs       Date:  2011-01-01       Impact factor: 5.857

4.  High-affinity single-domain binding proteins with a binary-code interface.

Authors:  Akiko Koide; Ryan N Gilbreth; Kaori Esaki; Valentina Tereshko; Shohei Koide
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-09       Impact factor: 11.205

5.  Two-state selection of conformation-specific antibodies.

Authors:  Junjun Gao; Sachdev S Sidhu; James A Wells
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-10       Impact factor: 11.205

6.  The full amino acid repertoire is superior to serine/tyrosine for selection of high affinity immunoglobulin G binders from the fibronectin scaffold.

Authors:  Benjamin J Hackel; K Dane Wittrup
Journal:  Protein Eng Des Sel       Date:  2010-01-12       Impact factor: 1.650

7.  Accelerating phage-display library selection by reversible and site-specific biotinylation.

Authors:  Akiko Koide; John Wojcik; Ryan N Gilbreth; Annett Reichel; Jacob Piehler; Shohei Koide
Journal:  Protein Eng Des Sel       Date:  2009-09-08       Impact factor: 1.650

8.  Design of protein function leaps by directed domain interface evolution.

Authors:  Jin Huang; Akiko Koide; Koki Makabe; Shohei Koide
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-29       Impact factor: 11.205

9.  Discovery and Characterization of a Novel CD4-Binding Adnectin with Potent Anti-HIV Activity.

Authors:  David Wensel; Yongnian Sun; Zhufang Li; Sharon Zhang; Caryn Picarillo; Thomas McDonagh; David Fabrizio; Mark Cockett; Mark Krystal; Jonathan Davis
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

10.  A potent and highly specific FN3 monobody inhibitor of the Abl SH2 domain.

Authors:  John Wojcik; Oliver Hantschel; Florian Grebien; Ines Kaupe; Keiryn L Bennett; John Barkinge; Richard B Jones; Akiko Koide; Giulio Superti-Furga; Shohei Koide
Journal:  Nat Struct Mol Biol       Date:  2010-03-28       Impact factor: 15.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.